Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Senate Committee on Health, Education, Labor & Pensions
Pharma
Novo CEO agrees to discuss potential GLP-1 price cuts with PBMs
At the Senate committee hearing on Novo Nordisk's Ozempic and Wegovy prices, insurance-related debate took up much of the conversation.
Zoey Becker
Sep 24, 2024 5:03pm
After subpoena threat, Novo CEO Jorgensen will testify at Senate
Jun 17, 2024 11:07am
Sanders seeks subpoena for Novo exec to answer pricing questions
Jun 12, 2024 8:01am
Sanders issues dire warning about projected GLP-1 spending
May 16, 2024 7:05am
Novo Nordisk grilled by Sanders over steep GLP-1 pricing
Apr 25, 2024 2:58pm
J&J, Merck CEOs answer Sanders' summon for pricing testimony
Jan 26, 2024 3:49pm
65e7.jpg?VersionId=HcEbagt.YOtkQVRw3roQO3uc2EWN6NJf)
